PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 20, 2013Anesthesia & Analgesia2 citations

Noninvasive Cardiac Output Monitoring With Nexfin

View Full Paper
MFMarc-Olivier FischerJFJean-Luc Fellahi

Key Result

Nexfin for noninvasive cardiac output monitoring requires further phase III clinical utility studies before definitive recommendations can be made for routine clinical practice.

Structured PICO

Does noninvasive cardiac output monitoring with Nexfin agree with pulmonary artery catheter measurements in cardiac surgery patients?

P
Population
Patients after elective cardiac surgery (as discussed in the referenced study)
I
Intervention
Noninvasive cardiac output monitoring with Nexfin
C
Comparator
Pulmonary artery catheter
O
Outcome
Agreement in cardiac output measurementssurrogate

Methodological concerns regarding studies comparing Nexfin to pulmonary artery catheters suggest that further phase III studies are needed before routine clinical adoption.

Limitations

  • Cardiac output measurements were performed consecutively rather than simultaneously.
  • Classic Bland-Altman analysis was used instead of a technique dedicated to multiple observations per individual.
  • Patients were studied during stable hemodynamic conditions, limiting extrapolation to patients with changing hemodynamics.
  • Recent studies showed weak correlation and percentage errors greater than 50% after fluid challenge.

Abstract

To the Editor In a recent article, Bubenek-Turconi et al.1 compared 2 devices for measuring cardiac output (CO), namely the Nexfin (BMEYE, Amsterdam, Netherlands) and the pulmonary artery catheter. While we agree that the Nexfin is a safe, noninvasive, continuous, easy to use, and nonoperator dependent monitor, several limitations regarding the conduct of the study are of concern. First, CO measurements using the 2 methods were performed consecutively rather than simultaneously. Second, because multiple measurements of CO were performed in the same patients, the classic Bland-Altman analysis should be replaced by a technique dedicated to evaluating the agreement between both CO monitors with multiple observations per individual.2 Third, the patients were studied during stable hemodynamic conditions after elective cardiac surgery, and thus, the results cannot be extrapolated to all patients in whom hemodynamics may be changing. Fourth, 3 recent studies3–5 performed after a fluid challenge in cardiac surgical or critically ill patients showed weak correlation between changes in CO between both devices and percentage errors greater than 50%. Until phase III studies (clinical utility/outcome) in different subgroups of patients and surgeries, no definitive recommendation about the Nexfin should be made for clinical routine practice. Marc-Olivier Fischer, MD Jean-Luc Fellahi, MD, PhD Department of Anesthesiology and Critical Care University Hospital of Caen Caen, France email protected email protected

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fischer et al. (2013) conducted a letter in Cardiac surgery. Nexfin vs. Pulmonary artery catheter was evaluated. Nexfin for noninvasive cardiac output monitoring requires further phase III clinical utility studies before definitive recommendations can be made for routine clinical practice.

synapsesocial.com/papers/6a81b3d9b7134f4e3dee27f6https://doi.org/10.1213/ane.0000000000000006
Ask AI
Helpful
Bookmark
Share
View Full Paper